Carcinoma of the kidney, testis, and rare urologic malignancies

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 23, Issue 5, 2000, Pages 431-437

  Petrovich, Zbigniew ^a   Baert, Luc V ^b   Brady, Luther W ^d   De Ridder, Dirk J M K ^b   Goethuys, Hans ^b   Nijman, Rien ^e   Oyen, Raymond ^c   Ozer, Howard ^d   Roskams, Tania ^b   Stein, John P ^a   Stockx, Luc ^c   Van Oosterom, Allan ^b   Van Poppel, Hein P ^b   Van Uytsel, Luc ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d ALLEGHENY UNIVERSITY HOSPITALS   (United States)

^e SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Diagnosis; Kidney; Testis cancer; Therapy

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; KIDNEY TUMOR; MOLECULAR GENETICS; NEPHRECTOMY; QUALITY OF LIFE; TESTIS TUMOR; URINARY TRACT CANCER; UROGENITAL TRACT TUMOR;

FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; TESTICULAR NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 0034443894     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200010000-00001     Document Type: Article

References (63)

1. Cancer statistics, CA
2. The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: The Indiana University experience (1965-1989)
3. The surgical management of renal cell carcinoma
4. The surgical management for renal cell carcinoma: Long term results in large group of patients
5. Radical nephrectomy
6. Tobacco use in relation to renal cell carcinoma
7. Comparison of the descriptive epidemiology of urinary tract cancers
8. Diagnosis and management of patients with complicated cystic lesions of the kidney
9. MR imaging evaluation of renal cell carcinoma
10. Paraneoplastic manifestations of renal cell carcinoma
11. Clinical signs and symptoms of renal cell carcinoma
12. Prognostic significance of incidental renal cell carcinoma
13. Enquete epidemiologique sur les tumeurs du rein
14. Staging renal cell carcinoma
15. Prognostic factors in renal cell cancer
16. Radical nephrectomy for renal cell carcinoma
17. Malignant neoplasms of the kidney: An analysis of 353 patients followed five years or more
18. Microscopic venous infiltration as predictor of relapse in renal cell carcinoma
19. Extension of renal cell carcinoma into the vena cava: The rationale for aggressive surgical management
20. Evaluation of the new tumor, nodes, and metastases classification of renal cell carcinoma
21. The role of lymphadenectomy in the management of renal cell carcinoma
22. What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma?
23. Ueber nierenexstirpation
24. Conservative renal surgery for adenocarcinoma: The place of bench surgery
25. Progression and survival after renal-conserving surgery for renal cell carcinoma: Experience in 104 patients and extended follow-up
26. Partial nephrectomy for renal cell carcinoma: Indications, results and implications
27. The role of nephron-sparing surgery in renal cell carcinoma
28. Elective conservative surgery for renal cell carcinoma
29. Nephron-sparing in incidental versus suspected renal cell carcinoma
30. Conservative surgery in patients with unilateral renal cell cancer and a normal contralateral unit: Experience with 60 patients
31. Management of small unilateral renal cell carcinomas: Radical versus nephron-sparing surgery
32. Elective nephron-sparing surgery for renal cell carcinoma
33. Specific release of granulocyte-macrophage colony stimulating factor, tumor necrosis factor-alpha and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation
34. The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma
35. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy
36. Immunotherapy and gene therapy
37. Interferon in urological tumors-renal cell carcinoma
38. Concomitant administration of recombinant of human interleukin-2 and recombinant interferon alpha-2a: An active outpatient regimen in metastatic renal cell carcinoma
39. The role of radiotherapy in the management of patients with renal cell carcinoma
40. Preoperative external beam radiotherapy followed by cytoreductive surgery and intraoperative radiotherapy for locally advanced primary or recurrent renal malignancies
41. Radiotherapy of metastases from renal cancer
42. Stereotactic radiosurgery in the treatment of metastatic disease to the brain
43. Stereotactic radiosurgery for primary and metastatic brain tumors
44. Radiation therapy in the treatment of metastatic renal cell carcinoma
45. Testicular cancer
46. Increase in testicular cancer incidence in six European countries: A birth cohort phenomenon
47. An explanation for the increasing incidence of testis cancer: Decreasing age at first full-term pregnancy
48. Risk of testicular cancer in cohort of boys with cryptorchidism
49. A segregation analysis of testicular cancer based on Norwegian and Swedish families
50. Does vasectomy cause testicular cancer?
51. Non-seminomatous testis tumors: A plan of management based on 96 patients to improve survival in all stages by combined therapeutic modalities
52. Imaging of the testis: Comparison between MR imaging and US
53. Proper staging techniques in testicular cancer patients
54. The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: The Indiana University experience (1965-1989)
55. Clinical stage I testicular cancer: The role of modified retroperitoneal lymphadenectomy
56. Orchidectomy alone in stage I non-seminomatous germ cell tumors
57. A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10 year follow-up
58. Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer
59. Chemotherapy of metastatic seminoma: The Southeastern Cancer Study Group experience
60. Advanced seminoma: Treatment with cisplatinum-based combination chemotherapy or carboplatin (JM8)
61. Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience
62. Correlation of computerized tomographic changes and histologic findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer
63. The growing teratoma syndrome